Yoomin Jeon and Siun Kim were awarded the Best Oral Presentation Award at the 2021 KSCPT Conference.The Best Oral Presentation Award aims to recognize outstanding scientific papers delivered through oral presentations at the conference. The awards were given to oral presentations of the paper titled "A Randomized, Double-blind, Placebo- and Active-controlled, Escalating Single-dose Study to Evaluate Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasians" and "An Annotated Corpus and Natural Language Processing Model for Drug Safety Information Extraction from Free-texts Reporting Adverse Events" for Yoomin and Siun, respectively.
Yoomin presented the results of a phase 1 clinical trial evaluating the pharmacokinetics and pharmacodynamics of eflapegrastim following subcutaneous administration to healthy subjects. Eflapegrastim (Rolontis®) is a novel, long-acting Granulocyte-Colony Stimulating Factor (G-CSF) being studied as a treatment for neutropenia that utilizes Hanmi's Labscovery, a proprietary platform technology.
Siun presented an annotated corpus for extracted Korean adverse events using free-texts from the KAERS (Korean Adverse Event Reporting System) database. To this end, Siun Kim developed deep learning models that automatically extract medication and adverse event information, cooperating with MILAB in Seoul National University.
HOME
